The Paradoxical Relationship between White Matter, Psychopathology and Cognition in Schizophrenia: A Diffusion Tensor and Proton Spectroscopic Imaging Study

Neuropsychopharmacology

Volumn 40, Issue 9, 2015, Pages 2248-2257

  Caprihan, Arvind ^a   Jones, Thomas ^a   Chen, Hongji ^a   Lemke, Nicholas ^a   Abbott, Christopher ^a   Qualls, Clifford ^a   Canive, Jose ^a,b,c   Gasparovic, Charles ^a   Bustillo, Juan R ^a,b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID; ASPARTIC ACID; N-ACETYLASPARTATE; PROTON;

ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; FRACTIONAL ANISOTROPY; GLIA CELL; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MYELINATION; NEGATIVE SYNDROME; OCCIPITOFRONTAL FASCICULUS; POSITIVE SYNDROME; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; SYMPTOMATOLOGY; WHITE MATTER; ADULT; AGED; ANALOGS AND DERIVATIVES; COGNITION DISORDERS; COMPLICATION; FEMALE; IMAGE PROCESSING; MALE; METABOLISM; MIDDLE AGED; NEAR INFRARED SPECTROSCOPY; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STATISTICS; YOUNG ADULT;

ADULT; AGED; ASPARTIC ACID; COGNITION DISORDERS; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROTONS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPATHOLOGY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SPECTROSCOPY, NEAR-INFRARED; STATISTICS AS TOPIC; WHITE MATTER; YOUNG ADULT;

EID: 84937162658     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.72     Document Type: Article

References (43)

1. Boos HB, Mandl RC, van Haren NE, Cahn W, van Baal GC, Kahn RS et al (2013). Tract-based diffusion tensor imaging in patients with schizophrenia and their non-psychotic siblings. Eur Neuropsychopharmacol 23: 295-304.
2. Buchanan RW, Davis M, Goff D, Green MF, Keefe RS, Leon AC et al (2005). A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. Schizophr Bull 31: 5-19.
3. Bustillo JR, Chen H, Gasparovic C, Mullins P, Caprihan A, Qualls C et al (2011). Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla. Biol Psychiatry 69: 19-27.
4. Catani M, Craig MC, Forkel SJ, Kanaan R, Picchioni M, Toulopoulou T et al (2011). Altered integrity of perisylvian language pathways in schizophrenia: relationship to auditory hallucinations. Biol Psychiatry 70: 1143-1150.
5. Cheung V, Chiu CP, Law CW, Cheung C, Hui CL, Chan KK et al (2011). Positive symptoms and white matter microstructure in never-medicated first episode schizophrenia. Psychol Med 41: 1709-1719.
6. Choi H, Kubicki M, Whitford TJ, Alvarado JL, Terry DP, Niznikiewicz M et al (2011). Diffusion tensor imaging of anterior commissural fibers in patients with schizophrenia. Schizophr Res 130: 78-85.
7. Cui L, Chen Z, Deng W, Huang X, Li M, Ma X et al (2011). Assessment of white matter abnormalities in paranoid schizophrenia and bipolar mania patients. Psychiatry Res 194: 347-353.
8. Deary IJ, Bastin ME, Pattie A, Clayden JD, Whalley LJ, Starr JM et al (2006). White matter integrity and cognition in childhood and old age. Neurology 66: 505-512.
9. Du F, Cooper A, Cohen BM, Renshaw PF, Ongur D (2012). Water and metabolite transverse T2 relaxation time abnormalities in the white matter in schizophrenia. Schizophr Res 137: 241-245.
10. Du F, Cooper AJ, Thida T, Shinn AK, Cohen BM, Ongur D (2013). Myelin and axon abnormalities in schizophrenia measured with magnetic resonance imaging techniques. Biol Psychiatry 74: 451-457.
11. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ (2010). International consensus study of antipsychotic dosing. Am J Psychiatry 167: 686-693.
12. Gasparovic C, Song T, Devier D, Bockholt HJ, Caprihan A, Mullins PG et al (2006). Use of tissue water as a concentration reference for proton spectroscopic imaging. Magn Reson Med 55: 1219-1226.
13. He ZL, Deng W, Li ML, Chen ZF, Collier DA, Ma X et al (2012). Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naive schizophrenia patients. Early Interv Psychiatry 6: 166-175.
14. Hoistad M, Segal D, Takahashi N, Sakurai T, Buxbaum JD, Hof PR (2009). Linking white and grey matter in schizophrenia: oligodendrocyte and neuron pathology in the prefrontal cortex. Front Neuroanat 3: 9.
15. Hubl D, Koenig T, Strik W, Federspiel A, Kreis R, Boesch C et al (2004). Pathways that make voices: white matter changes in auditory hallucinations. Arch Gen Psychiatry 61: 658-668.
16. Jardri R, Pouchet A, Pins D, Thomas P (2011). Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis. Am J Psychiatry 168: 73-81.
17. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1: 261-276.
18. Kitis O, Ozalay O, Zengin EB, Haznedaroglu D, Eker MC, Yalvac D et al (2012). Reduced left uncinate fasciculus fractional anisotropy in deficit schizophrenia but not in non-deficit schizophrenia. Psychiatry Clin Neurosci 66: 34-43.
19. Kraguljac NV, Reid M, White D, Jones R, den Hollander J, Lowman D et al (2012). Neurometabolites in schizophrenia and bipolar disorder-a systematic review and meta-analysis. Psychiatry Res 203: 111-125.
20. Lee SH, Kubicki M, Asami T, Seidman LJ, Goldstein JM, Mesholam-Gately RI et al (2013). Extensive white matter abnormalities in patients with first-episode schizophrenia: a diffusion tensor imaging (DTI) study. Schizophr Res 143: 231-238.
21. Mori S, Oishi K, Jiang H, Jiang L, Li X, Akhter K et al (2008). Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage 40: 570-582.
22. Mulert C, Kirsch V, Whitford TJ, Alvarado J, Pelavin P, McCarley RW et al (2012). Hearing voices: a role of interhemispheric auditory connectivity? World J Biol Psychiatry 13: 153-158.
23. Perez-Iglesias R, Tordesillas-Gutierrez D, Barker GJ, McGuire PK, Roiz-Santianez R, Mata I et al (2010). White matter deffects in first episode psychosis patients: a voxelwise analysis of diffusion tensor imaging. Neuroimage 49: 199-204.
24. Provencher SW (1993). Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30: 672-679.
25. Rae CD (2014). A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem Res 39: 1-36.
26. Reis Marques T, Taylor H, Chaddock C, Dell'acqua F, Handley R, Reinders AA et al (2014). White matter integrity as a predictor of response to treatment in first episode psychosis. Brain 137: 172-182.
27. Rowland LM, Spieker EA, Francis A, Barker PB, Carpenter WT, Buchanan RW (2009). White matter alterations in deficit schizophrenia. Neuropsychopharmacology 34: 1514-1522.
28. Schmithorst VJ, Wilke M, Dardzinski BJ, Holland SK (2005). Cognitive functions correlate with white matter architecture in a normal pediatric population: a diffusion tensor MRI study. Hum Brain Mapp 26: 139-147.
29. Sen PN, Basser PJ (2005). Modeling diffusion in white matter in the brain: a composite porous medium. Magn Reson Imaging 23: 215-220.
30. Seok JH, Park HJ, Chun JW, Lee SK, Cho HS, Kwon JS et al (2007). White matter abnormalities associated with auditory hallucinations in schizophrenia: a combined study of voxel-based analyses of diffusion tensor imaging and structural magnetic resonance imaging. Psychiatry Res 156: 93-104.
31. Shergill SS, Kanaan RA, Chitnis XA, O'Daly O, Jones DK, Frangou S et al (2007). A diffusion tensor imaging study of fasciculi in schizophrenia. Am J Psychiatry 164: 467-473.
32. Skelly LR, Calhoun V, Meda SA, Kim J, Mathalon DH, Pearlson GD (2008). Diffusion tensor imaging in schizophrenia: relationship to symptoms. Schizophr Res 98: 157-162.
33. Skudlarski P, Schretlen DJ, Thaker GK, Stevens MC, Keshavan MS, Sweeney JA et al (2013). Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry 170: 886-898.
34. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE et al (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487-1505.
35. Smith SM, Nichols The (2009). Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44: 83-98.
36. Steel RM, Bastin ME, McConnell S, Marshall I, Cunningham-Owens DG, Lawrie SM et al (2001). Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls. Psychiatry Res 106: 161-170.
37. Steen RG, Hamer RM, Lieberman JA (2005). Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30: 1949-1962.
38. Szeszko PR, Narr KL, Phillips OR, McCormack J, Sevy S, Gunduz-Bruce H et al (2012). Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia. Schizophr Bull 38: 569-578.
39. Szeszko PR, Robinson DG, Ashtari M, Vogel J, Betensky J, Sevy S et al (2008). Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuro-psychopharmacology 33: 976-984.
40. Tang CY, Friedman J, Shungu D, Chang L, Ernst T, Stewart D et al (2007). Correlations between diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (1H MRS) in schizophrenic patients and normal controls. BMC Psychiatry 7: 25.
41. Wang Q, Cheung C, Deng W, Li M, Huang C, Ma X et al (2013). Fronto-parietal white matter microstructural deficits are linked to performance IQ in a first-episode schizophrenia Han Chinese sample. Psychol Med 43: 2047-2056.
42. Wang Q, Cheung C, Deng W, Li M, Huang C, Ma X et al (2013). White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment. Psychol Med 43: 2301-2309.
43. Whitford TJ, Kubicki M, Schneiderman JS, O'Donnell LJ, King R, Alvarado JL et al (2010). Corpus callosum abnormalities and their association with psychotic symptoms in patients with schizophrenia. Biol Psychiatry 68: 70-77.